Bone marrow angiogenesis in myeloma and its precursor disease: a prospective clinical trial

Leukemia. 2014 Feb;28(2):413-6. doi: 10.1038/leu.2013.268. Epub 2013 Sep 18.

Authors

M Bhutani¹, B Turkbey², E Tan¹, T J Kemp³, L A Pinto³, A R Berg¹, N Korde¹, A R Minter¹, B M Weiss¹, E Mena², L Lindenberg², O Aras², M P Purdue⁴, J N Hofmann⁴, S M Steinberg⁵, K R Calvo⁶, P L Choyke², I Maric⁶, K Kurdziel², O Landgren¹

Affiliations

¹ Multiple Myeloma Section, CCR, NCI, NIH, Bethesda, MD, USA.
² Molecular Imaging Program, CCR, NCI, NIH, Bethesda, MD, USA.
³ HPV Immunology Laboratory, SAIC-Frederick, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
⁴ Division of Cancer Epidemiology and Genetics, NCI, NIH, Bethesda, MD, USA.
⁵ Biostatistics and Data Management Section, CCR, NCI, NIH, Bethesda, MD, USA.
⁶ Hematology Section, CCR, DLM, NIH, Bethesda, MD, USA.

No abstract available

Publication types

Clinical Trial
Letter
Research Support, N.I.H., Intramural

MeSH terms

Bone Marrow / pathology*
Humans
Magnetic Resonance Imaging
Monoclonal Gammopathy of Undetermined Significance / diagnosis
Monoclonal Gammopathy of Undetermined Significance / pathology*
Multiple Myeloma / diagnosis
Multiple Myeloma / pathology*
Neovascularization, Pathologic*

Associated data

ClinicalTrials.gov/NCT01237054

Grants and funding

Z01 CP010136-12/Intramural NIH HHS/United States